TrinityPoint Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$10.3M Buy
58,169
+318
+0.5% +$56.5K 1.45% 9
2024
Q3
$11.4M Buy
57,851
+31
+0.1% +$6.12K 1.64% 9
2024
Q2
$9.92M Sell
57,820
-863
-1% -$148K 1.55% 10
2024
Q1
$10.7M Buy
58,683
+653
+1% +$119K 1.77% 9
2023
Q4
$8.99M Sell
58,030
-4,151
-7% -$643K 1.63% 9
2023
Q3
$9.27M Buy
62,181
+666
+1% +$99.3K 1.85% 7
2023
Q2
$8.29M Buy
61,515
+1,273
+2% +$172K 1.62% 8
2023
Q1
$9.6M Buy
60,242
+1,314
+2% +$209K 2.06% 7
2022
Q4
$9.52M Buy
58,928
+367
+0.6% +$59.3K 2.17% 6
2022
Q3
$7.86M Buy
58,561
+161
+0.3% +$21.6K 1.8% 9
2022
Q2
$8.95M Buy
58,400
+4,416
+8% +$676K 1.98% 8
2022
Q1
$8.75M Buy
53,984
+3,640
+7% +$590K 1.58% 10
2021
Q4
$6.82M Buy
50,344
+144
+0.3% +$19.5K 1.21% 14
2021
Q3
$5.42M Buy
50,200
+795
+2% +$85.8K 1.04% 19
2021
Q2
$5.57M Buy
49,405
+423
+0.9% +$47.6K 1.14% 16
2021
Q1
$5.3M Buy
48,982
+436
+0.9% +$47.2K 1.23% 16
2020
Q4
$5.28M Buy
48,546
+16,065
+49% +$1.75M 1.27% 14
2020
Q3
$2.85M Buy
32,481
+19,784
+156% +$1.73M 0.79% 31
2020
Q2
$1.25M Buy
12,697
+185
+1% +$18.2K 0.39% 71
2020
Q1
$953K Buy
12,512
+1,582
+14% +$120K 0.38% 72
2019
Q4
$968K Sell
10,930
-6,109
-36% -$541K 0.33% 74
2019
Q3
$1.41M Buy
17,039
+9,704
+132% +$805K 0.49% 53
2019
Q2
$495K Sell
7,335
-165
-2% -$11.1K 0.24% 100
2019
Q1
$604K Buy
7,500
+4,479
+148% +$361K 0.3% 89
2018
Q4
$278K Buy
+3,021
New +$278K 0.17% 127